- Home
- GMM vs VRCA Comparison
GMM vs VRCA Comparison
Compare GMM & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMM
- VRCA
- Stock Information
- Founded
- GMM 2017
- VRCA 2013
- Country
- GMM China
- VRCA United States
- Employees
- GMM N/A
- VRCA N/A
- Industry
- GMM
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- GMM
- VRCA Health Care
- Exchange
- GMM Nasdaq
- VRCA Nasdaq
- Market Cap
- GMM 70.8M
- VRCA 58.0M
- IPO Year
- GMM 2023
- VRCA 2018
- Fundamental
- Price
- GMM $3.23
- VRCA $0.42
- Analyst Decision
- GMM
- VRCA Hold
- Analyst Count
- GMM 0
- VRCA 5
- Target Price
- GMM N/A
- VRCA $6.00
- AVG Volume (30 Days)
- GMM 34.9K
- VRCA 539.1K
- Earning Date
- GMM 05-16-2025
- VRCA 03-11-2025
- Dividend Yield
- GMM N/A
- VRCA N/A
- EPS Growth
- GMM 62.17
- VRCA N/A
- EPS
- GMM 6.37
- VRCA N/A
- Revenue
- GMM $41,360,953.00
- VRCA $7,566,000.00
- Revenue This Year
- GMM N/A
- VRCA $93.38
- Revenue Next Year
- GMM N/A
- VRCA $127.27
- P/E Ratio
- GMM $0.51
- VRCA N/A
- Revenue Growth
- GMM 53.82
- VRCA 47.66
- 52 Week Low
- GMM $0.21
- VRCA $0.39
- 52 Week High
- GMM $4.97
- VRCA $11.41
- Technical
- Relative Strength Index (RSI)
- GMM 36.14
- VRCA 30.67
- Support Level
- GMM $3.00
- VRCA $0.39
- Resistance Level
- GMM $4.21
- VRCA $0.66
- Average True Range (ATR)
- GMM 0.43
- VRCA 0.07
- MACD
- GMM -0.07
- VRCA -0.01
- Stochastic Oscillator
- GMM 17.71
- VRCA 16.87
About GMM Global Mofy Metaverse Limited
Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.